Ultragenyx Pharmaceutical Inc. Underwriting Agreements
9 Contracts & Agreements
- Underwriting Agreement, dated as of June 13, 2024, among Ultragenyx Pharmaceutical Inc. and J.P. Morgan Securities LLC, Goldman Sachs & Co. LLC, BofA Securities, Inc., and TD... (Filed With SEC on June 17, 2024)
- Underwriting Agreement, dated as of October 18, 2023, among Ultragenyx Pharmaceutical Inc. and J.P. Morgan Securities LLC, Goldman Sachs & Co. LLC, BofA Securities, Inc., and... (Filed With SEC on October 23, 2023)
- Underwriting Agreement, dated as of October 28, 2020, among Ultragenyx Pharmaceutical Inc. and J.P. Morgan Securities LLC, Goldman Sachs & Co. LLC, BofA Securities, Inc., and... (Filed With SEC on November 2, 2020)
- Underwriting Agreement, dated as of February 26, 2019, among Ultragenyx Pharmaceutical Inc. and J.P. Morgan Securities LLC, Goldman Sachs & Co. LLC, Merrill Lynch, Pierce, Fenner... (Filed With SEC on March 1, 2019)
- Underwriting Agreement, dated as of January 23, 2018, among Ultragenyx Pharmaceutical Inc. and J.P. Morgan Securities LLC, Merrill Lynch, Pierce, Fenner & Smith Incorporated,... (Filed With SEC on January 26, 2018)
- ULTRAGENYX PHARMACEUTICAL INC. 2,200,000 Shares of Common Stock Underwriting Agreement (Filed With SEC on July 21, 2015)
- ULTRAGENYX PHARMACEUTICAL INC. 3,000,000 Shares of Common Stock Underwriting Agreement (Filed With SEC on February 10, 2015)
- ULTRAGENYX PHARMACEUTICAL INC. [] Shares of Common Stock Underwriting Agreement (Filed With SEC on July 7, 2014)
- ULTRAGENYX PHARMACEUTICAL INC. [ ] Shares of Common Stock Underwriting Agreement (Filed With SEC on January 17, 2014)
